标题
The aurora kinases in cell cycle and leukemia
作者
关键词
-
出版物
ONCOGENE
Volume 34, Issue 5, Pages 537-545
出版商
Springer Nature
发表日期
2014-03-17
DOI
10.1038/onc.2014.14
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
- (2013) S. I. Nikolaev et al. BLOOD
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
- (2013) Seiichi Okabe et al. Cancer Cell International
- Aurora B inhibitor barasertib and cytarabine exert a greater-than-additive cytotoxicity in acute myeloid leukemia cells
- (2013) Takahiro Yamauchi et al. CANCER SCIENCE
- A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
- (2013) E. Raymond et al. INVESTIGATIONAL NEW DRUGS
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
- (2013) J D E de Rooij et al. LEUKEMIA
- A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
- (2013) Carlos Graux et al. LEUKEMIA RESEARCH
- Gene Amplification and Overexpression of Aurora-C in Breast and Prostate Cancer Cell Lines
- (2013) Ali Zekri et al. ONCOLOGY RESEARCH
- Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro
- (2012) Mohsin Shah et al. BLOOD CELLS MOLECULES AND DISEASES
- An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
- (2012) Tanja A. Gruber et al. CANCER CELL
- Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia
- (2012) Mike Dennis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
- (2012) Qiang Wen et al. CELL
- The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent
- (2012) Jayasree S. Nair et al. CELL CYCLE
- Conditional Aurora A deficiency differentially affects early mouse embryo patterning
- (2012) Yeonsoo Yoon et al. DEVELOPMENTAL BIOLOGY
- Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism
- (2012) Kevin R. Kelly et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models
- (2012) Clarisse Thiollier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
- (2012) S A Hartsink-Segers et al. LEUKEMIA
- Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells
- (2012) Aarthi Jayanthan et al. LEUKEMIA & LYMPHOMA
- Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)
- (2012) Fei Fei et al. Molecular Cancer
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
- (2011) B. Lowenberg et al. BLOOD
- Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model
- (2011) Hongfeng Yuan et al. CARCINOGENESIS
- The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents
- (2011) Deborah R. Wysong et al. CELL CYCLE
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- Genetic disruption of aurora B uncovers an essential role for aurora C during early mammalian development
- (2011) G. Fernandez-Miranda et al. DEVELOPMENT
- Normal and malignant megakaryopoiesis
- (2011) Qiang Wen et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia-a study of 531 Southeast Asian children by the Ma-Spore study group
- (2011) Shuangjie Leow et al. HEMATOLOGICAL ONCOLOGY
- AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas
- (2011) Wenqing Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora A and Aurora B jointly coordinate chromosome segregation and anaphase microtubule dynamics
- (2011) Nadia Hégarat et al. JOURNAL OF CELL BIOLOGY
- Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells
- (2011) Jen-Hui Tsou et al. JOURNAL OF PATHOLOGY
- A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia
- (2011) Kosuke Tsuboi et al. LEUKEMIA RESEARCH
- Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation
- (2011) Jabbar Khan et al. PLoS One
- Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process
- (2010) L. Lordier et al. BLOOD
- The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
- (2010) Kevin R. Kelly et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
- (2009) A. Oke et al. CANCER RESEARCH
- Deregulated Aurora-B induced tetraploidy promotes tumorigenesis
- (2009) Hao G. Nguyen et al. FASEB JOURNAL
- Molecular Distinctions between Aurora A and B: A Single Residue Change Transforms Aurora A into Correctly Localized and Functional Aurora B
- (2009) Fabienne Hans et al. MOLECULAR BIOLOGY OF THE CELL
- Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
- (2009) P. Kaestner et al. MOLECULAR CANCER THERAPEUTICS
- A single amino acid change converts Aurora-A into Aurora-B-like kinase in terms of partner specificity and cellular function
- (2009) J. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
- (2009) I. Radtke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating mutations in human acute megakaryoblastic leukemia
- (2008) S. Malinge et al. BLOOD
- Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling
- (2008) L. Lordier et al. BLOOD
- Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
- (2008) E. Walsby et al. HAEMATOLOGICA
- Aurora A Is Essential for Early Embryonic Development and Tumor Suppression
- (2008) Lin-Yu Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity†
- (2008) Steven Howard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development
- (2008) D. O. Cowley et al. MOLECULAR AND CELLULAR BIOLOGY
- Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
- (2008) Libor Macůrek et al. NATURE
- Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
- (2008) A. Seki et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started